Cup is a nucleocytoplasmic shuttling protein that interacts with the eukaryotic translation initiation factor 4E to modulate Drosophila ovary development

od Zappavigna, Vincenzo, Piccioni, Federica, Villaescusa, J. Carlos, Verrotti, Arturo C.
Izdano 2004

Extracellular Signal-regulated Kinase 8 (ERK8) Controls Estrogen-related Receptor α (ERRα) Cellular Localization and Inhibits Its Transcriptional Activity

od Rossi, Matteo, Colecchia, David, Iavarone, Carlo, Strambi, Angela, Piccioni, Federica, Verrotti di Pianella, Arturo, Chiariello, Mario
Izdano 2011

A genome-scale CRISPR screen identifies the ERBB and mTOR signalling networks as key determinants of response to PI3K inhibition in pancreatic cancer

od Milton, Charlotte K., Self, Annette J., Clarke, Paul A., Banerji, Udai, Piccioni, Federica, Root, David E., Whittaker, Steven R.
izdano v Mol Cancer Ther (2020)

Genotype-fitness maps of EGFR-mutant lung adenocarcinoma chart the evolutionary landscape of resistance for combination therapy optimization

od Bolan, Patrick, Zviran, Asaf, Brenan, Lisa, Schiffman, Joshua S., Dusaj, Neville, Goodale, Amy, Piccioni, Federica, Johannessen, Cory M., Landau, Dan A.
izdano v Cell Syst (2019)

Comprehensive mutational analysis of the BRCA1-associated DNA helicase and tumor suppressor, FANCJ/BACH1/BRIP1

od Calvo, Jennifer A, Fritchman, Briana, Hernandez, Desiree, Persky, Nicole S, Johannessen, Cory M, Piccioni, Federica, Kelch, Brian A., Cantor, Sharon B
izdano v Mol Cancer Res (2021)

MAPK15/ERK8 stimulates autophagy by interacting with LC3 and GABARAP proteins

od Colecchia, David, Strambi, Angela, Sanzone, Sveva, Iavarone, Carlo, Rossi, Matteo, Dall’Armi, Claudia, Piccioni, Federica, Verrotti di Pianella, Arturo, Chiariello, Mario
Izdano 2012

Morphological Profiles of RNAi-Induced Gene Knockdown Are Highly Reproducible but Dominated by Seed Effects

od Singh, Shantanu, Wu, Xiaoyun, Ljosa, Vebjorn, Bray, Mark-Anthony, Piccioni, Federica, Root, David E., Doench, John G., Boehm, Jesse S., Carpenter, Anne E.
izdano v PLoS One (2015)

A melanocyte lineage program confers resistance to MAP kinase pathway inhibition

od Johannessen, Cory M., Johnson, Laura A., Piccioni, Federica, Townes, Aisha, Frederick, Dennie T., Donahue, Melanie K., Narayan, Rajiv, Flaherty, Keith T., Wargo, Jennifer A., Root, David E., Garraway, Levi A.
Izdano 2013

Optimized libraries for CRISPR-Cas9 genetic screens with multiple modalities

od Sanson, Kendall R., Hanna, Ruth E., Hegde, Mudra, Donovan, Katherine F., Strand, Christine, Sullender, Meagan E., Vaimberg, Emma W., Goodale, Amy, Root, David E., Piccioni, Federica, Doench, John G.
izdano v Nat Commun (2018)

A functional landscape of resistance to MEK1/2 and CDK4/6 inhibition in NRAS mutant melanoma

od Hayes, Tikvah K., Luo, Flora, Cohen, Ofir, Goodale, Amy B., Lee, Yenarae, Pantel, Sasha, Bagul, Mukta, Piccioni, Federica, Root, David E., Garraway, Levi A., Meyerson, Matthew, Johannessen, Cory M.
izdano v Cancer Res (2019)

MEDU-36. BCL2 FAMILY MEMBERS ATTENUATE RESPONSE OF MYC-DRIVEN MEDULLOBLASTOMAS TO BET-BROMODOMAIN INHIBITION

od Clymer, Jessica, Gionet, Gabrielle, Gonzalez, Elizabeth, Buchan, Graham, Qian, Kenin, Ho, Patricia, O’Rourke, Ryan, Balboni-Iniguez, Amanda, Stegmaier, Kimberley, Ligon, Keith, Piccioni, Federica, Johannessen, Cory, Beroukhim, Rameen, Bandopadhayay, Pratiti
izdano v Neuro Oncol (2019)

Predicting cell health phenotypes using image-based morphology profiling

od Way, Gregory P., Kost-Alimova, Maria, Shibue, Tsukasa, Harrington, William F., Gill, Stanley, Piccioni, Federica, Becker, Tim, Shafqat-Abbasi, Hamdah, Hahn, William C., Carpenter, Anne E., Vazquez, Francisca, Singh, Shantanu
izdano v Mol Biol Cell (2021)

Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers

od Rosenbluh, Joseph, Mercer, Johnathan, Shrestha, Yashaswi, Oliver, Rachel, Tamayo, Pablo, Doench, John G., Tirosh, Itay, Piccioni, Federica, Hartenian, Ella, Horn, Heiko, Fagbami, Lola, Root, David E., Jaffe, Jacob, Lage, Kasper, Boehm, Jesse S., Hahn, William C.
izdano v Cell Syst (2016)

TRTH-15. RESISTANCE MECHANISMS TO BET-BROMODOMAIN INHIBITION IN MYC-AMPLIFIED MEDULLOBLASTOMA

od Bandopadhayay, Pratiti, Paolella, Brenton, O’Rourke, Ryan, Ho, Patricia, Greenwald, Noah, Sharpira, Ofer, Pantel, Sasha, Bagul, Mukta, Tracy, Adam, Roti, Giovanni, Balboni, Amanda, Vazquez, Francisca, Ligon, Keith, Piccioni, Federica, Stegmaier, Kimberly, Johannessen, Cory, Beroukhim, Rameen
izdano v Neuro Oncol (2017)

Genetic modifiers of EGFR dependence in non-small cell lung cancer

od Sharifnia, Tanaz, Rusu, Victor, Piccioni, Federica, Bagul, Mukta, Imielinski, Marcin, Cherniack, Andrew D., Pedamallu, Chandra Sekhar, Wong, Bang, Wilson, Frederick H., Garraway, Levi A., Altshuler, David, Golub, Todd R., Root, David E., Subramanian, Aravind, Meyerson, Matthew
izdano v Proc Natl Acad Sci U S A (2014)

ATXN1L, CIC, and ETS Transcription Factors Modulate Sensitivity to MAPK Pathway Inhibition

od Wang, Belinda, Krall, Elsa Beyer, Aguirre, Andrew James, Kim, Miju, Widlund, Hans Ragnar, Doshi, Mihir Bhavik, Sicinska, Ewa, Sulahian, Rita, Goodale, Amy, Cowley, Glenn Spencer, Piccioni, Federica, Doench, John Gerard, Root, David Edward, Hahn, William Chun
izdano v Cell Rep (2017)

KRAS and YAP1 converge to regulate EMT and tumor survival

od Shao, Diane D., Xue, Wen, Krall, Elsa B., Bhutkar, Arjun, Piccioni, Federica, Wang, Xiaoxing, Schinzel, Anna C., Sood, Sabina, Rosenbluh, Joseph, Kim, Jong W., Zwang, Yaara, Roberts, Thomas M., Root, David E., Jacks, Tyler, Hahn, William C.
Izdano 2014

Phenotypic characterization of a comprehensive set of MAPK1/ERK2 missense mutants

od Brenan, Lisa, Andreev, Aleksandr, Cohen, Ofir, Pantel, Sasha, Kamburov, Atanas, Cacchiarelli, Davide, Persky, Nicole S., Zhu, Cong, Bagul, Mukta, Goetz, Eva M., Burgin, Alex B., Garraway, Levi A., Getz, Gad, Mikkelsen, Tarjei S., Piccioni, Federica, Root, David E., Johannessen, Cory M.
izdano v Cell Rep (2016)

RAS-MAPK reactivation facilitates acquired resistance in FGFR1-amplified lung cancer and underlies a rationale for upfront FGFR-MEK blockade

od Bockorny, Bruno, Rusan, Maria, Chen, Wankun, Liao, Rachel G., Li, Yvonne, Piccioni, Federica, Wang, Jun, Tan, Li, Thorner, Aaron R., Li, Tianxia, Zhang, Yanxi, Miao, Changhong, Ovesen, Therese, Shapiro, Geoffrey I., Kwiatkowski, David J., Gray, Nathanael S., Meyerson, Matthew, Hammerman, Peter S., Bass, Adam J.
izdano v Mol Cancer Ther (2018)

Resistance mechanisms to SYK inhibition in acute myeloid leukemia

od Cremer, Anjali, Ellegast, Jana M., Alexe, Gabriela, Frank, Elizabeth S., Ross, Linda, Chu, S. Haihua, Pikman, Yana, Robichaud, Amanda, Goodale, Amy, Häupl, Björn, Mohr, Sebastian, Rao, Arati V., Walker, Alison R., Blachly, James S., Piccioni, Federica, Armstrong, Scott A., Byrd, John C., Oellerich, Thomas, Stegmaier, Kimberly
izdano v Cancer Discov (2019)